Pharma Focus Asia

Roche achieves two major milestones in the evolution of decision support platform

Monday, March 05, 2018

Roche, announces two major milestones in the evolution of the Decision Support platform being developed in its Diagnostics Information Solutions (DIS) business.

The first milestone is HITRUST CSF (Certifiable Security Framework) certification after an audit specific to the NAVIFY Tumor Board solution, DIS' inaugural offering launched last October. HITRUST CSF certification, granted January 18th, centers on cybersecurity in healthcare and is highly valued, especially in the United States.

Click here(https://www.navify.com/tumorboard/#security) to download our cloud security brochure.

The Roche DIS Belmont site also received ISO/IEC 27001 certification, which pertains to secure and compliant data handling. This is significant support to enable entry into European and Asian markets. Both of these certifications and their impact on patient data safety are timely subjects of discussion at the upcoming Health Information and Management Systems Society held March 5-9 in Las Vegas. Roche will have shared presence at the Accenture, Amazon Web Services (AWS), and ClearDATA partner booths where presentations on healthcare data security and demonstrations of the NAVIFY Tumor Board solution will be given. To learn more about Roche's presence at HIMSS, click here.

HITRUST CSF and ISO/IEC 27001 certifications call for accountability partners to continuously and independently review Roche's data protection protocols. These certifications affirm Roche's commitment to the highest standards of data care that allow the assurance of patient data protection while offering new, innovative products to their customers. These achievements also reflect Roche's Code of Conduct, including corporate responsibility, integrity, and respect for patient privacy. More in-depth technical information on these certifications can be found on the HITRUST and ISO/IEC 27001 organisations' web sites.

"With these two certifications, we have the quality marks customers look for," said Tim M. Jaeger, Global Head of Diagnostics Information Solutions. "Our customers' trust is sacred to us because we know just how important patient data is to all parties involved."

In addition to ongoing updates to the NAVIFY Tumor Board solution, additional products and applications are currently under development to build a world-class, integrated Decision Support portfolio. Through HITRUST CSF and ISO/IEC 27001 certifications, recognised information security standards and a flexible framework for prescriptive and scalable security controls help ensure patient data remains secure across the entire platform.

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024